Dziadziuszko R - Search Results

1

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.

Drilon A, Siena S, Dziadziuszko R, Barlesi F, Krebs MG, Shaw AT, de Braud F, Rolfo C, Ahn MJ, Wolf J, Seto T, Cho BC, Patel MR, Chiu CH, John T, Goto K, Karapetis CS, Arkenau HT, Kim SW, Ohe Y, Li YC, Chae YK, Chung CH, Otterson GA, Murakami H, Lin CC, Tan DSW, Prenen H, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Doebele RC; trial investigators. Drilon A, et al. Among authors: dziadziuszko r. Lancet Oncol. 2020 Feb;21(2):261-270. doi: 10.1016/S1470-2045(19)30690-4. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838015 Free PMC article.

2

Autopsy findings in small cell lung cancer.

Jereczek B, Jassem J, Karnicka-Młodkowska H, Badzio A, Mos-Antkowiak R, Szczepek B, Chojak E, Dziadziuszko R, Lisowska B, Malak K. Jereczek B, et al. Among authors: dziadziuszko r. Neoplasma. 1996;43(2):133-7. Neoplasma. 1996. PMID: 8843976

3

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

Dziadziuszko R, Ardizzoni A, Postmus PE, Smit EF, Price A, Debruyne C, Legrand C, Giaccone G; EORTC Lung Cancer Group. Dziadziuszko R, et al. Eur J Cancer. 2003 Jun;39(9):1271-6. doi: 10.1016/s0959-8049(03)00234-x. Eur J Cancer. 2003. PMID: 12763216 Clinical Trial.

4

Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.

Chmara M, Wozniak A, Ochman K, Kobierska G, Dziadziuszko R, Sosinska-Mielcarek K, Jassem E, Skokowski J, Jassem J, Limon J. Chmara M, et al. Among authors: dziadziuszko r. Anticancer Res. 2004 Nov-Dec;24(6):4259-63. Anticancer Res. 2004. PMID: 15736482 Free article.

5

Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.

Dziadziuszko R, Witta SE, Cappuzzo F, Park S, Tanaka K, Danenberg PV, Barón AE, Crino L, Franklin WA, Bunn PA Jr, Varella-Garcia M, Danenberg KD, Hirsch FR. Dziadziuszko R, et al. Clin Cancer Res. 2006 May 15;12(10):3078-84. doi: 10.1158/1078-0432.CCR-06-0106. Clin Cancer Res. 2006. PMID: 16707605

6

Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?

Dziadziuszko R, Hirsch FR, Varella-Garcia M, Bunn PA Jr. Dziadziuszko R, et al. Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4409s-4415s. doi: 10.1158/1078-0432.CCR-06-0087. Clin Cancer Res. 2006. PMID: 16857819 Review.

7

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.

Hirsch FR, Varella-Garcia M, Bunn PA Jr, Franklin WA, Dziadziuszko R, Thatcher N, Chang A, Parikh P, Pereira JR, Ciuleanu T, von Pawel J, Watkins C, Flannery A, Ellison G, Donald E, Knight L, Parums D, Botwood N, Holloway B. Hirsch FR, et al. Among authors: dziadziuszko r. J Clin Oncol. 2006 Nov 1;24(31):5034-42. doi: 10.1200/JCO.2006.06.3958. J Clin Oncol. 2006. PMID: 17075123 Clinical Trial.

8

Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.

Dziadziuszko R, Holm B, Skov BG, Osterlind K, Sellers MV, Franklin WA, Bunn PA Jr, Varella-Garcia M, Hirsch FR. Dziadziuszko R, et al. Ann Oncol. 2007 Mar;18(3):447-52. doi: 10.1093/annonc/mdl407. Epub 2006 Nov 2. Ann Oncol. 2007. PMID: 17082511 Free article.

9

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

Hirsch FR, Varella-Garcia M, Cappuzzo F, McCoy J, Bemis L, Xavier AC, Dziadziuszko R, Gumerlock P, Chansky K, West H, Gazdar AF, Crino L, Gandara DR, Franklin WA, Bunn PA Jr. Hirsch FR, et al. Among authors: dziadziuszko r. Ann Oncol. 2007 Apr;18(4):752-60. doi: 10.1093/annonc/mdm003. Epub 2007 Feb 22. Ann Oncol. 2007. PMID: 17317677 Free article.

10

Update on epidermal growth factor receptor inhibitor development in lung cancer.

Sequist LV, Dziadziuszko R. Sequist LV, et al. Among authors: dziadziuszko r. J Thorac Oncol. 2006 Sep;1(7):740-3. J Thorac Oncol. 2006. PMID: 17409951 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page